This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guiyoule, A.
Right arrow Articles by Carniel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guiyoule, A.
Right arrow Articles by Carniel, E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 1998, p. 2732-2734, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Phenotypic and Genotypic Characterization of Virulent Yersinia enterocolitica Strains Unable To Ferment Sucrose

Annie Guiyoule,1 Françoise Guinet,1 Liliane Martin,1 Catherine Benoit,1 Nicole Desplaces,2 and Elisabeth Carniel1,*

National Reference Laboratory and WHO Collaborating Center for Yersinia, Institut Pasteur, 75724 Paris Cedex 15,1 and Hôpital de la Croix Saint-Simon, 75960 Paris Cedex 20,2 France

Received 24 March 1998/Returned for modification 24 April 1998/Accepted 1 June 1998

    ABSTRACT
Top
Abstract
Text
References

Several atypical sucrose-negative Yersinia strains, isolated from clinical samples and sometimes associated with symptoms, proved to have full virulence potential in in vitro and in vivo testings. DNA-relatedness studies revealed that they were authentic Yersinia enterocolitica strains. Therefore, atypical sucrose-negative Yersinia isolates should be analyzed for their virulence potential.

    TEXT
Top
Abstract
Text
References

Some bioserotypes of Yersinia enterocolitica correlate with potential pathogenicity in humans (6, 10). Most commonly isolated in gastrointestinal infections are bioserotypes 4/O:3, 2/O:9, and 2-3/O:5-5,27 (5, 9). The Y. enterocolitica-related species can share antigenic reactivities with Y. enterocolitica sensu stricto, but they are avirulent.

Among the biochemical traits that differentially characterize these Y. enterocolitica-related and -sensu stricto species, lack of sucrose fermentation has been a distinct feature of Y. kristensenii (2, 3, 17). Consequently, sucrose-negative Y. enterocolitica-like organisms isolated from clinical specimens have been regarded as avirulent, and in routine practice, they are not characterized further. The present report, however, describes a series of sucrose-negative, Voges-Proskauer (VP)-positive Y. enterocolitica-like isolates that proved, upon thorough characterization, to be fully pathogenic strains of Y. enterocolitica.

Detection of atypical Y. enterocolitica-like clinical isolates. A Yersinia strain, IP22109, was recovered in large numbers on CIN agar base (Difco) from the feces of a 24-year-old man hospitalized at the La Croix St. Simon Hospital, Paris, France, for high fever (39°C), diarrhea, and pain in the right iliac fossa. This case was one of several cases of acute gastroenteritis traced to a common meal, suggesting a food-borne outbreak although this small outbreak was not further investigated. No other potentially pathogenic microorganism was isolated from the stool samples. IP22109 was of serotype O:5. The patient's serum was able to agglutinate the Y. enterocolitica O:5 reference strain as well as its homologous strain, indicating that the latter had triggered an immune response. IP22109 displayed an atypical biochemical profile, since sucrose negativity, typical of Y. kristensenii (3), was associated with a positive VP test which is negative in this species but is positive in Y. enterocolitica (3). The association between sucrose negativity and VP positivity has been occasionally observed in biotype 5 of Y. enterocolitica. This very uncommon biotype, however, is associated with serotype O:2,3, as opposed to serotype O:5 of IP22109.

A search of the 22,000-strain collection of the Yersinia Reference Laboratory and WHO Collaborating Center, Pasteur Institute, for sucrose-negative, VP-positive Yersinia isolates of serotype O:5 yielded four such strains. They all had been isolated from human stools, and the presence of concomitant digestive symptoms had been recorded for two of them (Table 1). They were, therefore, further characterized along with IP22109.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Characteristics of the sucrose-negative, VP-positive Y. enterocolitica strains used in this studya

In vitro and in vivo virulence tests. Pathogenic Yersinia strains carry the 70-kb pYV plasmid, which encodes essential virulence determinants. Four in vitro tests were used to address the presence of pYV in the five atypical isolates. Indirect assessment of the plasmid presence was obtained by (i) plating the strains on magnesium-oxalate agar (MOX test) in search for the growth inhibition triggered by the pYV plasmid under low-calcium conditions at 37°C (11, 16) and (ii) checking bacterial autoagglutination mediated by the pYV-encoded YadA adhesin upon incubation at 37°C in RPMI medium (1, 13). Direct detection of pYV was then performed by colony hybridization with a yadA-specific probe and by plasmid extraction. The MOX and autoagglutination tests were done as described previously (11, 13). The yadA-specific probe used for colony hybridization was obtained by nested PCR of plasmid DNA from Y. enterocolitica IP864 with the pairs of primers 5'-CTGCAAATAAGCTATACCGAT-3' and 5'-ATGCCTGACTAGAACGATAT-3' for the first reaction, and 5'-GTGACTGTAAGTAGTTCGACT-3' and 5'-CCGACACCTGCAGTAAAGTT-3' for the second reaction. PCRs and digoxigenin labeling during the second PCR were performed as published previously (8), except that the first PCR was done with 10 ng of template DNA and with primers at a final concentration of 1 µM each, and in the second PCR, each unlabeled nucleotide was at a final concentration of 40 µM. The first PCR mixture was denatured at 94°C for 2 min and then amplified for 24 cycles at 94°C for 1 min, 54°C for 1 min 30 s, and 72°C for 2 min. The last cycle was followed by a 10-min incubation at 72°C. Amplification products were reamplified with the second primer set and the same PCR parameters as above, except for the priming step, which was carried out at 58°C. Colony transfer and hybridization were performed as published previously (8), and immunological detection of the probe was done according to the manufacturer's instructions (Boehringer). Plasmid extraction was performed according to the method of Birnboim and Doly (4).

As shown in Table 1 and Fig. 1, the results of the four pYV detection assays were in agreement and showed that all of the atypical strains except IP10664 harbored the 70-kb virulence plasmid. In the IP7230 Y. kristensenii control strain, these tests consistently failed to detect the plasmid.


View larger version (83K):
[in this window]
[in a new window]
 
FIG. 1.   Plasmid fingerprinting of the atypical isolates. EcoRI-restricted plasmids were resolved on a 0.8% agarose gel, ethidium bromide stained, and visualized under UV illumination. Comparison of the plasmid restriction patterns shows that most of the atypical strains harbor the pYV plasmid. Within the O:5 strains (lanes 1 to 6), the only detectable difference in the restriction profiles is an apparent size increase in a low-molecular-weight fragment of strains IP22914 and IP22109 (arrow). Lanes: 1, IP17381; 2, IP19817; 3, IP10664; 4, IP22109; 5, IP22914; 6, IP22228 (control Y. enterocolitica O:5 strain known to harbor pYV). The atypical strain of serotype O:9 (IP25686, lane 8) had a plasmid profile identical to that of the Y. enterocolitica O:9 control strain, IP23073 (lane 7). lambda  and M, lambda /HindIII and 1-kb-ladder molecular weight markers, respectively (GibcoBRL). Sizes are in kilobases.

The atypical isolates were also assayed for pyrazinamidase activity as a plasmid-independent virulence test (12). Absence of detectable pyrazinamidase activity, which correlates with potential pathogenicity in Y. enterocolitica and related organisms (12), was found to be a feature of all atypical isolates (Table 1). This result indicated that the atypical Yersinia strains were all potentially pathogenic, although one of them had lost its pYV plasmid.

The pathogenicity of the atypical strains was confirmed in vivo by using the iron-overloaded mouse model (15). All 50% lethal doses (LD50s) were determined as described previously (7) for groups of five intravenously infected OF1 female mice (Iffa Credo, France). The plasmid-harboring atypical strains proved to be as virulent as the pathogenic Y. enterocolitica IP22228 control, with LD50s ranging between 2 × 104 and 2 × 105 CFU (Table 1). The LD50 of the avirulent Y. kristensenii reference strain, IP7230, was markedly higher, with a more than 5,000-fold increase relative to that of the pathogenic Y. enterocolitica strains.

The virulence potential of the atypical strains demonstrated by the in vitro and in vivo testings was in keeping with the symptomatology associated with these strains (Table 1). It also strongly suggested that the atypical isolates belonged to Y. enterocolitica rather than to Y. kristensenii, since the pYV virulence plasmid is exclusively found in the three pathogenic species of Yersinia, i.e., Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica. Definitive species assignment was achieved by DNA-relatedness measurements.

Species assignment. DNA-DNA hybridizations were performed with the atypical strains IP10664 and IP19817 and the control strains Y. enterocolitica IP22228 and Y. kristensenii IP105, according to the protocol published by Popoff and Coynault (14). DNA labeling of the control strains, assessment of the degree of hybridization, and normalization to the homologous reaction were as described previously (14). As shown in Table 2, the atypical organisms shared a high degree of relatedness with the Y. enterocolitica control strain, IP22228 (>93%), and a low degree of relatedness (<= 49%) with the Y. kristensenii reference strain, IP105. Therefore, the DNA hybridization studies conclusively ascribed the atypical strains to the Y. enterocolitica species.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   DNA relatedness of two atypical Yersinia strains with a control Y. enterocolitica O:5 strain and the Y. kristensenii reference strain

Detection of an atypical Y. enterocolitica strain of bioserotype 2/O:9. One additional sucrose-negative, VP-positive Yersinia strain, IP25686, was identified in the Yersinia Reference Laboratory collection upon screening of the entire database. This strain was of bioserotype 2/O:9. IP25686 had the virulence characteristics of enteropathogenic Y. enterocolitica, because it belonged to a pathogenic bioserotype, possessed the pYV plasmid (Fig. 1), and lacked detectable pyrazinamidase activity (Table 1).

All of the sucrose-negative Y. enterocolitica strains, whatever their serotype, were of biotype 2 (Table 1). Since this biotype is much less common in France than biotype 4, its constant association with the loss of sucrose fermentation in this series might reflect a genetic or a biochemical linkage between the two phenotypic traits.

The results presented above demonstrate the existence of fully pathogenic sucrose-negative Y. enterocolitica strains within two of the most common pathogenic bioserotypes. The pYV plasmid-containing atypical Y. enterocolitica strains were pathogenic for mice to the same degree as a sucrose-positive control, indicating that full virulence of Y. enterocolitica in mice is not dependent on sucrose fermentation. Furthermore, the cluster of acute clinical cases associated with one atypical strain suggests that pathogenic potential in humans is retained upon loss of sucrose fermentation. Although loss of sucrose fermentation does not alter the virulence of Y. enterocolitica, the fact that this biochemical property is almost perfectly retained in the species suggests that it is beneficial for the bacterium, possibly when it is outside of its host.

An important clinical implication of this work is that sucrose-negative yersiniae can be virulent and can therefore be held responsible for acute and delayed pathologic manifestations typical of enteropathogenic yersiniae, e.g., enteritis, erythema nodosum, and arthropathies. Any sucrose-negative Y. enterocolitica-like organism with associated symptomatology should be characterized further, especially if the VP reaction is positive. Determination of the atypical isolate biotype, serotype, and, in certain cases, phagetype, along with the pyrazinamidase test may be simple means to orient the bacteriological diagnosis. If necessary, these tests should be completed by in vitro and in vivo virulence evaluations.

    ACKNOWLEDGMENTS

We thank David Yelton for critical reading of the manuscript.

    FOOTNOTES

* Corresponding author. Mailing address: Laboratoire des Yersinia, 28 rue du Dr Roux, 75724 Paris Cedex 15, France. Phone: 33-1-4568-8326. Fax: 33-1-4061-3001. E-mail: carniel2{at}pasteur.fr.

    REFERENCES
Top
Abstract
Text
References

1. Balligand, G., Y. Laroche, and G. Cornelis. 1985. Genetic analysis of virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: role of outer membrane protein P1 in resistance to human serum and autoagglutination. Infect. Immun. 48:782-786[Abstract/Free Full Text].
2. Bercovier, H., D. J. Brenner, J. Ursing, A. G. Steigerwalt, G. R. Fanning, J.-M. Alonso, G. P. Carter, and H. H. Mollaret. 1980. Characterization of Yersinia enterocolitica sensu stricto. Curr. Microbiol. 4:201-206.
3. Bercovier, H., J. Ursing, D. J. Brenner, A. G. Steigerwalt, G. R. Fanning, G. P. Carter, and H. H. Mollaret. 1980. Yersinia kristensenii: a new species of Enterobacteriaceae composed of sucrose-negative strains (formerly called atypical Yersinia enterocolitica or Yersinia enterocolitica-like). Curr. Microbiol. 4:219-224.
4. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523[Abstract/Free Full Text].
5. Bottone, E. J. 1981. Yersinia enterocolitica. CRC Press, Inc., Boca Raton, Fla.
6. Bottone, E. J. 1997. Yersinia enterocolitica: the charisma continues. Clin. Microbiol. Rev. 10:257-276[Abstract].
7. Carniel, E., A. Guiyoule, I. Guilvout, and O. Mercereau-Puijalon. 1992. Molecular cloning, iron-regulation and mutagenesis of the irp2 gene encoding HMWP2, a protein specific for the highly pathogenic Yersinia. Mol. Microbiol. 6:379-388[Medline].
8. Chenal, V., and R. Griffais. 1994. Chemiluminescent and colorimetric detection of a fluorescein-labelled probe and a digoxigenin-labelled probe after a single hybridization step. Mol. Cell. Probes 8:401-407[Medline].
9. Cornelis, G., Y. Laroche, G. Balligand, M.-P. Sory, and G. Wauters. 1987. Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev. Infect. Dis. 9:64-87[Medline].
10. Farmer, J. J., III, G. P. Carter, V. L. Miller, S. Falkow, and I. K. Wachsmuth. 1992. Pyrazinamidase, CR-MOX agar, salicin fermentation-esculin hydrolysis, and D-xylose fermentation for identifying pathogenic serotypes of Yersinia enterocolitica. J. Clin. Microbiol. 30:2589-2594[Abstract/Free Full Text].
11. Higuchi, K., and J. L. Smith. 1961. Studies on the nutrition and physiology of Pasteurella pestis. VI. A differential plating medium for the estimation of the mutation rate to avirulence. J. Bacteriol. 81:605-608[Free Full Text].
12. Kandolo, K., and G. Wauters. 1985. Pyrazinamidase activity in Yersinia enterocolitica and related organisms. J. Clin. Microbiol. 21:980-982[Abstract/Free Full Text].
13. Laird, W. J., and D. C. Cavanaugh. 1980. Correlation of autoagglutination and virulence of yersiniae. J. Clin. Microbiol. 11:430-432[Abstract/Free Full Text].
14. Popoff, M., and C. Coynault. 1980. Use of DEA-cellulose filters in the S1 nuclease method for bacterial deoxyribonucleic acid hybridization. Ann. Inst. Pasteur 131:151-155.
15. Robins-Browne, R. M., and J. Kaya Prpic. 1985. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect. Immun. 47:774-779[Abstract/Free Full Text].
16. Straley, S. C., and R. D. Perry. 1995. Environmental modulation of gene expression and pathogenesis in Yersinia. Trends Microbiol. 3(8):310-317[Medline].
17. Wauters, G., M. Janssens, A. G. Steigerwalt, and D. J. Brenner. 1988. Yersinia mollaretii sp. nov. and Yersinia bercovieri sp. nov., formerly called Yersinia enterocolitica biogroups 3A and 3B. Int. J. Syst. Bacteriol. 38:424-429[Abstract/Free Full Text].


Journal of Clinical Microbiology, September 1998, p. 2732-2734, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • STOCK, I., HENRICHFREISE, B., WIEDEMANN, B. (2002). Natural antibiotic susceptibility and biochemical profiles of Yersinia enterocolitica-like strains: Y. bercovieri, Y. mollaretii, Y. aldovae and 'Y. ruckeri'. J Med Microbiol 51: 56-69 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guiyoule, A.
Right arrow Articles by Carniel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guiyoule, A.
Right arrow Articles by Carniel, E.